Cancer Gene & Cell Therapy: Expanding Therapeutic Options With Living Drugs

Moderator:

  • Mike Rice, MS, MBA, Senior Consultant, Defined Health

Panelists:

  • Estuardo Aguilar-Cordova, PhD, Chief Executive Officer
    Advantagene, Inc.
  • Harry Gruber, MD, Chairman, Tocagen, Inc.
  • Angela Shen, MD, MBA, Global Clinical Program Head, CTL019, Oncology Clinical Development, Novartis Pharmaceuticals Corp